Literature DB >> 6107157

Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

D A Henry, I A Macdonald, G Kitchingman, G D Bell, M J Langman.   

Abstract

Paired studies of hepatic microsomal function were conducted in eight subjects during treatment with two histamine H2 antagonists, cimetidine and ranitidine. Cimetidine but not ranitidine inhibited the metabolism of antipyrine (phenazone) and demethylation of aminopyrine (aminophenazone) as measured by breath 14CO2 production after intravenous injection of 14C-aminopyrine. These results suggest that the metabolic inhibitory actions on the liver may be separated from H2 antagonist effects, and that ranitidine has an advantage over cimetidine by not inhibiting microsomal drug oxidative function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107157      PMCID: PMC1714006          DOI: 10.1136/bmj.281.6243.775

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

Review 1.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Interaction of cimetidine with liver microsomes.

Authors:  S Rendić; V Sunjić; R Toso; F Kajfez; H H Ruf
Journal:  Xenobiotica       Date:  1979-09       Impact factor: 1.908

3.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

4.  The [14C]-aminopyrine breath test. A comparison of different forms of analysis.

Authors:  D A Henry; G Sharpe; S Chaplain; S Cartwright; G Kitchingman; G D Bell; M J Langman
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

5.  Rate of drug metabolism in man measured by 14CO2-breath analysis.

Authors:  R Platzer; R L Galeazzi; G Karlaganis; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

6.  Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.

Authors:  N R Peden; J H Saunders; K G Wormsley
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

7.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

8.  Cimetidine and ranitidine in duodenal ulcer.

Authors:  M J Langman; D A Henry; G B Bell; W R Burnham; A Ogilvy
Journal:  Br Med J       Date:  1980-08-16
  8 in total
  50 in total

1.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

2.  An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.

Authors:  L Purkins; S D Oliver; S A Willavize
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

Review 3.  Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A H Price; R N Brogden
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

4.  Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-Doppler ultrasonic flowmeter.

Authors:  Y Sasaki; N Hayashi; A Kasahara; Y Matsuda; S Furusawa; H Fusamoto; N Sato; T Kamada
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  Lack of inhibitory effect of metronidazole on theophylline disposition in healthy subjects.

Authors:  G I Adebayo; A F Mabadeje
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

6.  The role of H2 receptor antagonist premedication in pregnant day care patients.

Authors:  J G Stock; A D Sutherland
Journal:  Can Anaesth Soc J       Date:  1985-09

7.  Cimetidine versus famotidine: the effect on the pharmacokinetics of theophylline in rats.

Authors:  P Mojaverian; M L Rocci; C L Saccar; P H Vlasses; R K Ferguson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Apr-Jun       Impact factor: 2.441

8.  Lack of effect of ranitidine on warfarin action.

Authors:  M J Serlin; R G Sibeon; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

Review 9.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

10.  The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits.

Authors:  N L Harris; D E Brenner; L B Anthony; J C Collins; S Halter; K R Hande
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.